Mojca Stegnar
Impact in
- Internal Medicine top 2%
- Venous Thromboembolism Diagnosis and Management
- Hematology top 2%
- Blood Coagulation and Thrombosis Mechanisms
- Platelet Disorders and Treatments
Papers in
- Hematology 55
- Blood Coagulation and Thrombosis Mechanisms 50
- Platelet Disorders and Treatments 5
-
- Venous Thromboembolism Diagnosis and Management 6
- Co-authors
- Polona Peternel (23 shared papers)Mojca Božič Mijovski (21 shared papers)Dusan Keber (15 shared papers)Katja Breskvar (4 shared papers)Vita Dolzan (4 shared papers)Alenka Mavri (4 shared papers)D. Kikelj (9 shared papers)Aleš Blinc (8 shared papers)
- Journals
- Thrombosis Research (14 papers)Thrombosis and Haemostasis (8 papers)Clinical Chemistry and Laboratory Medicine (CCLM) (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Medicinal Chemistry (3 papers)
- Partner nations
- SloveniaAustriaNetherlands
In The Last Decade
Mojca Stegnar
74 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 81
- Internal Medicine 139
- Hematology 462
- Pharmacology 222
- Cardiology and Cardiovascular Medicine 114
- Rheumatology 65
Countries citing papers authored by Mojca Stegnar
This map shows the geographic impact of Mojca Stegnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mojca Stegnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mojca Stegnar more than expected).
Fields of papers citing papers by Mojca Stegnar
This network shows the impact of papers produced by Mojca Stegnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mojca Stegnar. The network helps show where Mojca Stegnar may publish in the future.
Co-authors
The 25 scholars most cited alongside Mojca Stegnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 108 | |
| 2 | 2006 | 101 | |
| 3 | 1999 | 93 | |
| 4 | 1996 | 77 | |
| 5 | 2008 | 63 | |
| 6 | 2005 | 50 | |
| 7 | 2002 | 49 | |
| 8 | 1993 | 45 | |
| 9 | 2006 | 41 | |
| 10 | 2004 | 39 | |
| 11 | 2004 | 34 | |
| 12 | 2001 | 30 | |
| 13 | 1991 | 29 | |
| 14 | 2003 | 29 | |
| 15 | 1990 | 26 | |
| 16 | 2006 | 25 | |
| 17 | 1979 | 23 | |
| 18 | 2002 | 23 | |
| 19 | 2009 | 22 | |
| 20 | 1979 | 21 |
About Mojca Stegnar
Mojca Stegnar is a scholar working on Hematology, Internal Medicine, Pulmonary and Respiratory Medicine, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 76 papers that have together received 1.4k indexed citations. Recurring topics across this work include Blood Coagulation and Thrombosis Mechanisms (50 papers), Blood properties and coagulation (9 papers), Venous Thromboembolism Diagnosis and Management (6 papers), Synthesis and biological activity (6 papers), Platelet Disorders and Treatments (5 papers), Peripheral Artery Disease Management (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). The work is most often cited by research in Internal Medicine (139 citations), Hematology (462 citations), Pharmacology (222 citations), Cardiology and Cardiovascular Medicine (114 citations) and Rheumatology (65 citations). Mojca Stegnar has collaborated with scholars based in Slovenia, Austria and Netherlands. Frequent co-authors include Polona Peternel, Mojca Božič Mijovski, Dusan Keber, Katja Breskvar, Vita Dolzan, Alenka Mavri, D. Kikelj, Aleš Blinc, Nina Vene and Janez Ilaš. Their work appears in journals such as Thrombosis Research, Thrombosis and Haemostasis, Clinical Chemistry and Laboratory Medicine (CCLM), Bioorganic & Medicinal Chemistry Letters and European Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.